志賀病による糖尿病、腎症、網膜症の進行

基本情報

NCT ID: NCT00846716
ステータス: 不明
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 400
治験依頼者名: Shiga University

概要

The purpose of this study is to investigate whether the oral anti-diabetic drug, Thiazolidine (TZD) is effective in suppression of onset or progressin of diabetic nephropathy in Japanese type 2 diabetic patients.

対象疾患

Type 2 Diabetes Mellitus

介入

Pioglitazone add on to SU or biguanide(DRUG)

SU or Biguanide(DRUG)

依頼者（Sponsor）

Tomita Clinic(UNKNOWN)

Ako City Hospital(OTHER)

Toyosato Hospital(UNKNOWN)

Osaka University(OTHER)

Omihachiman Community Medical Center(UNKNOWN)

Kanazawa Medical University(OTHER)

Nagahama City Hospital(OTHER)

Kohka Public Hospital(UNKNOWN)

Social Insurance Shiga Hospital(UNKNOWN)

Shiga Clinic(UNKNOWN)

Nagahama Red Cross Hospital(OTHER)

Hyogo Prefectural Amagasaki Hospital(UNKNOWN)

Horide Clinic(UNKNOWN)

Yasu Hospital(UNKNOWN)

Sawada Clinic(UNKNOWN)

Ntt West Osaka Hospital(UNKNOWN)

Second Okamoto General Hospital(UNKNOWN)

Seta Clinic(UNKNOWN)

Kawabata Clinic(UNKNOWN)

Shiga University(OTHER)

実施施設 (1)

滋賀医科大学医学部附属病院

Ōtsu, Shiga, Japan(RECRUITING)